Cor Vasa 2007, 49(4):152-154
Tissue factor and the soluble ligand CD40 in patients with acute coronary syndrome
- 1 I. interní klinika
- 2 II. interní klinika
- 3 Ústav klinické biochemie a diagnostiky
- 4 Ústav klinické imunologie a alergologie, Lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Hradec Králové, Hradec Králové, Česká republika
The plasma levels of tissue factor (TF) and the soluble ligand CD40 (sLCD40) were assessed in the coronary sinus (CS), left coronary artery (LCA), and a peripheral vein (PV) of patients with acute coronary syndrome (Group A) and stable coronary artery disease (Group B). Altogether, 28 subjects (age 62.6 ± 10.3 years, 19 males, 9 females) were included into Group A and 24 patients (age 62.3 ± 8.1 years, 21 males, 3 females) into Group B. The plasma levels of sLCD40 were significantly higher in the CS of patients in Group A as compared to those in group B (9070.5 ± 4539.3 pg/mL vs. 6841.4 ± 3283.8 pg/mL, p = 0.026). Also the difference in sLCD40 between CS and LCA was significantly higher in Group A as compared to Group B (Figure 1). A significant linear correlation between the plasma levels of TF and sLCD40 was found (Figure 2). The plasma levels of sLCD40 in Group A showed a trend towards a non-significant increase on Day 7 as compared to Day 0 (Figure 3).
Keywords: Acute coronary syndrome; Tissue factor; Soluble ligand CD40
Published: April 1, 2007 Show citation
References
- Vojáček J. Aktivace cirkulujících působků a elementů - klíč k patofyziologii akutního koronárního syndromu. Cor Vasa 2005;47:265-7.
- Freedman JE. CD40 ligand - assessing risk instead of damage? New Engl J Med 2003;348:1163-5.
Go to original source...
Go to PubMed...
- Mach F, Schonbeck U, Libby P. CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis 1998;137 Suppl:S89-S95.
Go to original source...
Go to PubMed...
- Bavendiek U, Libby P, Kilbride M, Reynolds R, Mackman N, Schonbeck U. Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J Biol Chem 2002;277:25032-9.
Go to original source...
Go to PubMed...
- Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-4.
Go to original source...
Go to PubMed...
- May AE, Kalsch T, Massberg S, Herouy Y, Schmidt R, Gawaz M. Engagement of glycoprotein IIb/IIIa (alpha (IIb) beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 2002;106:2111-7.
Go to original source...
Go to PubMed...
- Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92:1041-8.
Go to original source...
Go to PubMed...
- Aukrust P, Muller F, Ueland T, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999;100:614-20.
Go to original source...
Go to PubMed...
- Garlichs CD, Eskafi S, Raaz D, et al. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 2001;86:649-55.
Go to original source...
Go to PubMed...
- Varo N, de Lemos JA, Libby P, et al. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 2003;108:1049-52.
Go to original source...
Go to PubMed...
- Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes. New Engl J Med 2003;348:1104-11.
Go to original source...
Go to PubMed...
- Freedman JE, Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 2002;105:2130-2.
Go to original source...
Go to PubMed...